France Neuroscience Market Size, Share, and COVID-19 Impact Analysis, By Component (Instruments, Consumables), By Technology (Neuro-Microscopy, Brain Imaging), and France Neuroscience Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI13013
PAGES 174
REPORT FORMAT PathSoft

France Neuroscience Market Size Insights Forecasts to 2035 

  • The France Neuroscience Market Size was Estimated at USD 2,113.5 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 6.28% from 2025 to 2035
  • The France Neuroscience Market Size is Expected to Reach USD 4,131.1 Million by 2035

France Neuroscience Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, the France Neuroscience Market Size is anticipated to reach USD 4,131.1 Million by 2035, growing at a CAGR of 6.28% from 2025 to 2035. This is due to the rising incidence of neurological conditions like Alzheimer's, brain cancer, epilepsy, and traumatic brain injuries.

 

Market Overview 

The France Neuroscience Market Size includes all commercial activities involved in the study of andotherapy for the nervous system. This would include developing and providing technological products and services to better understand, diagnose, and/or treat neurological disorders, and recognizing the application of neuroscience concepts in areas like marketing (neuromarketing). Several factors drive the market, including the rising number of people with neurological disorders, advances in neuro-imaging, and an increased awareness surrounding mental health. The neuroscience Market includes the study of the nervous system, including everything from its structure to development, function, and disease. It is commonly accepted that the human brain contains 86 billion neurons. Neurobiology is the branch of biology that pertains to the biological components of the nervous system. Neurological disorders are issues with the brain, spinal cord, and neuromuscular systems, including, but not limited to, epilepsy, brain tumors, Alzheimer's disease, and head trauma. The study of how the brain functions is done through neuroimaging, such as functional MRI, and other forms of EEG. Functional MRI and EEG are also used to study changes in brain function.

 

Report Coverage

This research report categorizes the market for the France neuroscience market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France neuroscience market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France neuroscience market. 

 

France Neuroscience Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 2,113.5 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 : 6.28%
2035 Value Projection:USD 4,131.1 Million
Historical Data for:2020-2023
No. of Pages:174
Tables, Charts & Figures:123
Segments covered:By Component, By Technology and COVID-19 Impact Analysis
Companies covered::Carl Zeiss AG, Koninklijke Philips N.V., Terumo Corporation, Boston Scientific Corporation, Danaher Corporation, B. Braun SE, Stryker, GE Healthcare, Canon Inc., ABBOTT, Medtronic, and Other key vendors
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The France neuroscience market is driven by the increase in neurological diseases has become a key concern for medical practitioners. The increase in lifespan has led to tremendous growth in the geriatric population. The older population is at high risk of developing degenerative neurological diseases such as Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Neurological conditions are the main cause of physical and mental disability, affecting approximately the population.

 

Restraining Factors

The France neuroscience market is driven by the intricate structure and operation of the human brain presents serious obstacles. Understanding how neural circuitry generates cognition, emotion, and behavior is still challenging. For example, while advancements have been achieved, the neural basis of subjective experience and consciousness is poorly understood.

 

Market Segmentation

The France Neuroscience market share is classified into component and technology.

 

  • The instruments segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France neuroscience market is segmented by component into instruments, consumables. Among these, the instruments segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The introduction of new instruments and devices for the diagnosis and treatment of neurological disorders is to blame for this.  Radiologists need high-quality images to make accurate diagnoses, and this device can provide them.

 

  • The brain imaging segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France neuroscience market is segmented by technology into neuro-microscopy, brain imaging. Among these, the brain imaging segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is because more hospitals, diagnostic facilities, and ambulatory surgical centers (ASCs) are using brain imaging tools like MRI, EEG, and CT scans to identify neurological conditions.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France neuroscience market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

 

List of Key Companies

  • Carl Zeiss AG
  • Koninklijke Philips N.V.
  • Terumo Corporation
  • Boston Scientific Corporation
  • Danaher Corporation
  • B. Braun SE
  • Stryker
  • GE Healthcare
  • Canon Inc.
  • ABBOTT
  • Medtronic
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Neuroscience Market based on the below-mentioned segments:

 

France Neuroscience Market, By Component                                                               

  • Instruments
  • Consumables

 

France Neuroscience Market, By Technology                                                                     

  • Neuro-Microscopy
  • Brain Imaging

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies